Zobrazeno 1 - 10
of 102
pro vyhledávání: '"T, Abshire"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Stefanie DiGiandomenico, Pamela A. Christopherson, Sandra L. Haberichter, Thomas C. Abshire, Robert R. Montgomery, Veronica H. Flood, L. Valentino, T. Abshire, A. Dunn, C. Bennett, J. Lusher, M. Rajpurkar, W.K. Hoots, D. Brown, A. Shapiro, J. Di Paola, S. Lentz, J. Gill, C. Leissinger, M. Ragni, J. Hord, M. Manco‐Johnson, A. Ma, L. Boggio, A. Sharathkumar, R. Gruppo, B. Kerlin, J. Journeycake, R. Kulkarni, D Mahoney, L. Mathias, A. Bedros, C. Diamond, A. Neff, A. Paroskie, D. DiMichele, P. Giardina, A. Cohen, M. Paidas, E. Werner, A. Matsunaga, T. Singer, M. Tarantino, J. Roberts, F. Shafer, B. Konkle, A. Cuker, P. Kouides, D. Stein, D. Lillicrap, P. James
Publikováno v:
J Thromb Haemost
Essentials Patients with von Willebrand disease were enrolled in our study. Type 2 VWD diagnoses were based on original test results. Repeat evaluation resulted in many patients receiving a different type 2 diagnosis. Some genetic variants were parti
Autor:
Pamela A. Christopherson, Sandra L. Haberichter, Veronica H. Flood, Crystal L. Perry, Brooke E. Sadler, Daniel B. Bellissimo, Jorge Di Paola, Robert R. Montgomery, T Abshire, H Weiler, D Lillicrap, P James, J O’Donnell, C Ng, C Bennett, R Sidonio, M Manco‐Johnson, J Journeycake, A Zia, J Lusher, M Rajpurkar, A Shapiro, S Lentz, J Gill, C Leissinger, M Ragni, M Tarantino, J Roberts, J Hord, J Strouse, A Ma, L Valentino, L Boggio, A Sharathkumar, R Gruppo, B Kerlin, R Kulkarni, D Green, K Hoots, D Brown, D Mahoney, L Mathias, A Bedros, C Diamond, A Neff, D DiMichele, P Giardina, A Cohen, M Paidas, E Werner, A Matsunaga, F Shafer, B Konkle, A Cuker, P Kouides, D Stein
Publikováno v:
Journal of thrombosis and haemostasis : JTHREFERENCES. 20(7)
Type 3 von Willebrand Disease (VWD) is a rare and severe form of VWD characterized by the absence of von Willebrand factor (VWF).As part of the Zimmerman Program, we sought to explore the molecular pathogenesis, correlate bleeding phenotype and sever
Autor:
Hana Cho, Elizabeth T. Abshire, Maximilian W. Popp, Christoph Pröschel, Joshua L. Schwartz, Gene W. Yeo, Lynne E. Maquat
Publikováno v:
Molecular cell. 82(15)
Despite a long appreciation for the role of nonsense-mediated mRNA decay (NMD) in destroying faulty, disease-causing mRNAs and maintaining normal, physiologic mRNA abundance, additional effectors that regulate NMD activity in mammalian cells continue
Autor:
Kelsey L. Hughes, Sarah F Pearce, Rucheng Diao, Raymond C. Trievel, Elizabeth T. Abshire, Aaron C. Goldstrohm, Peter L. Freddolino, Joanna Rorbach
Nocturnin (NOCT) is a eukaryotic enzyme that belongs to a superfamily of exoribonucleases, endonucleases, and phosphatases. In this study, we analyze the expression, processing, localization, and cellular functions of human NOCT. We demonstrate that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7ed22e10e031a0e3077bdcdfa0e5d11
Publikováno v:
RNA Biology
Post-transcriptional control of messenger RNA (mRNA) is an important layer of gene regulation that modulates mRNA decay, translation, and localization. Eukaryotic mRNA decay begins with the catalytic removal of the 3′ poly-adenosine tail by deadeny
Autor:
Peter L. Freddolino, Elizabeth T. Abshire, Jennifer Chasseur, Raymond C. Trievel, Paul A. Del Rizzo, Jennifer A. Bohn, Aaron C. Goldstrohm
Publikováno v:
Nucleic Acids Research
The circadian protein Nocturnin (NOCT) belongs to the exonuclease, endonuclease and phosphatase superfamily and is most similar to the CCR4-class of deadenylases that degrade the poly-adenosine tails of mRNAs. NOCT-deficient mice are resistant to hig
Publikováno v:
Post-transcriptional Mechanisms in Endocrine Regulation ISBN: 9783319251226
Post-transcriptional control plays a pervasive role in the regulation of gene expression, with direct relevance to the proper function of endocrine systems. This chapter explores the mechanisms that control protein expression at the levels of transla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6def6962858ce7f3aec8cdf34025a30
https://doi.org/10.1007/978-3-319-25124-0_1
https://doi.org/10.1007/978-3-319-25124-0_1
Autor:
N.A. Goldenberg, T. Abshire, P.J. Blatchford, L.Z. Fenton, J.L. Halperin, W.R. Hiatt, C.M. Kessler, J.M. Kittelson, M.J. Manco‐Johnson, A.C. Spyropoulos, P.G. Steg, N.V. Stence, A.G.G. Turpie, S. Schulman, R. Punzalan, M. Wang, J. Jaffray, G. Young, M. Rajpurkar, S. Carpenter, Y. Diab, N. Verdun, C. Tarango, S. Acharya, M. Torres, N. Kucine, B. Mitchell, N. Shah, C. Thornburg, C. Takemoto, R. Kulkarni, S. O'Brien, K. Haley, M. Recht, C. Knoll, A. Geddis, S. Ahuja, M. Simpson, L. Srivaths, J. Journeycake, A. Zia
Summary Background Randomized controlled trials (RCTs) on pediatric venous thromboembolism (VTE) treatment have been challenged by unsubstantiated design assumptions and/or poor accrual. Pilot/feasibility (P/F) studies are critical to future RCT succ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cce9a8ca1d2661a8084688ea510099f6
https://europepmc.org/articles/PMC4561031/
https://europepmc.org/articles/PMC4561031/
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.